LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 2 of total 2

Search options

  1. Article: Engineered Immunogens to Elicit Antibodies Against Conserved Coronavirus Epitopes.

    Kapingidza, Brenda / Marston, Daniel J / Harris, Caitlin / Wrapp, Daniel / Winters, Kaitlyn / Mielke, Dieter / Xiaozhi, Lu / Yin, Qi / Foulger, Andrew / Parks, Rob / Barr, Maggie / Newman, Amanda / Schäfer, Alexandra / Eaton, Amanda / Flores, Justine Mae / Harner, Austin / Cantazaro, Nicholas J / Mallory, Michael L / Mattocks, Melissa D /
    Beverly, Christopher / Rhodes, Brianna / Mansouri, Katayoun / Itallie, Elizabeth Van / Vure, Pranay / Manness, Brooke / Keyes, Taylor / Stanfield-Oakley, Sherry / Woods, Christopher W / Petzold, Elizabeth A / Walter, Emmanuel B / Wiehe, Kevin / Edwards, Robert J / Montefiori, David / Ferrari, Guido / Baric, Ralph / Cain, Derek W / Saunders, Kevin O / Haynes, Barton F / Azoitei, Mihai L

    bioRxiv : the preprint server for biology

    2023  

    Abstract: Immune responses to SARS-CoV-2 primarily target the receptor binding domain of the spike protein, which continually mutates to escape acquired immunity. Other regions in the spike S2 subunit, such as the stem helix and the segment encompassing residues ... ...

    Abstract Immune responses to SARS-CoV-2 primarily target the receptor binding domain of the spike protein, which continually mutates to escape acquired immunity. Other regions in the spike S2 subunit, such as the stem helix and the segment encompassing residues 815-823 adjacent to the fusion peptide, are highly conserved across sarbecoviruses and are recognized by broadly reactive antibodies, providing hope that vaccines targeting these epitopes could offer protection against both current and emergent viruses. Here we employed computational modeling to design scaffolded immunogens that display the spike 815-823 peptide and the stem helix epitopes without the distracting and immunodominant RBD. These engineered proteins bound with high affinity and specificity to the mature and germline versions of previously identified broadly protective human antibodies. Epitope scaffolds interacted with both sera and isolated monoclonal antibodies with broadly reactivity from individuals with pre-existing SARS-CoV-2 immunity. When used as immunogens, epitope scaffolds elicited sera with broad betacoronavirus reactivity and protected as "boosts" against live virus challenge in mice, illustrating their potential as components of a future pancoronavirus vaccine.
    Language English
    Publishing date 2023-09-17
    Publishing country United States
    Document type Preprint
    DOI 10.1101/2023.02.27.530277
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Engineered immunogens to elicit antibodies against conserved coronavirus epitopes.

    Kapingidza, A Brenda / Marston, Daniel J / Harris, Caitlin / Wrapp, Daniel / Winters, Kaitlyn / Mielke, Dieter / Xiaozhi, Lu / Yin, Qi / Foulger, Andrew / Parks, Rob / Barr, Maggie / Newman, Amanda / Schäfer, Alexandra / Eaton, Amanda / Flores, Justine Mae / Harner, Austin / Catanzaro, Nicholas J / Mallory, Michael L / Mattocks, Melissa D /
    Beverly, Christopher / Rhodes, Brianna / Mansouri, Katayoun / Van Itallie, Elizabeth / Vure, Pranay / Dunn, Brooke / Keyes, Taylor / Stanfield-Oakley, Sherry / Woods, Christopher W / Petzold, Elizabeth A / Walter, Emmanuel B / Wiehe, Kevin / Edwards, Robert J / Montefiori, David C / Ferrari, Guido / Baric, Ralph / Cain, Derek W / Saunders, Kevin O / Haynes, Barton F / Azoitei, Mihai L

    Nature communications

    2023  Volume 14, Issue 1, Page(s) 7897

    Abstract: Immune responses to SARS-CoV-2 primarily target the receptor binding domain of the spike protein, which continually mutates to escape acquired immunity. Other regions in the spike S2 subunit, such as the stem helix and the segment encompassing residues ... ...

    Abstract Immune responses to SARS-CoV-2 primarily target the receptor binding domain of the spike protein, which continually mutates to escape acquired immunity. Other regions in the spike S2 subunit, such as the stem helix and the segment encompassing residues 815-823 adjacent to the fusion peptide, are highly conserved across sarbecoviruses and are recognized by broadly reactive antibodies, providing hope that vaccines targeting these epitopes could offer protection against both current and emergent viruses. Here we employ computational modeling to design scaffolded immunogens that display the spike 815-823 peptide and the stem helix epitopes without the distracting and immunodominant receptor binding domain. These engineered proteins bind with high affinity and specificity to the mature and germline versions of previously identified broadly protective human antibodies. Epitope scaffolds interact with both sera and isolated monoclonal antibodies with broadly reactivity from individuals with pre-existing SARS-CoV-2 immunity. When used as immunogens, epitope scaffolds elicit sera with broad betacoronavirus reactivity and protect as "boosts" against live virus challenge in mice, illustrating their potential as components of a future pancoronavirus vaccine.
    MeSH term(s) Humans ; Animals ; Mice ; Epitopes ; Antibodies, Viral ; SARS-CoV-2 ; Immunodominant Epitopes ; Peptides ; Spike Glycoprotein, Coronavirus ; Antibodies, Neutralizing
    Chemical Substances Epitopes ; Antibodies, Viral ; Immunodominant Epitopes ; Peptides ; Spike Glycoprotein, Coronavirus ; Antibodies, Neutralizing
    Language English
    Publishing date 2023-11-30
    Publishing country England
    Document type Journal Article
    ZDB-ID 2553671-0
    ISSN 2041-1723 ; 2041-1723
    ISSN (online) 2041-1723
    ISSN 2041-1723
    DOI 10.1038/s41467-023-43638-9
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top